DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

9.07 0.23 (2.55%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARIA $9.07 2.55%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.85
Previous Close $8.84
Daily Range $8.82 - $9.07
52-Week Range $4.90 - $9.89
Market Cap $1.7B
P/E Ratio -10.05
Dividend (Yield) $0.00 (0.0%)
Volume 2,855,434
Average Daily Volume 5,275,103
Current FY EPS -$1.10




Drug Makers

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website:

News & Commentary

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

Michael Price Invests in 11 Companies in First Quarter

Stifel Talks 5 Biotech Stocks

ARIAD (ARIA) Q1 Loss Wider than Estimates; Iclusig Grows - Analyst Blog

ARIAD (ARIA) Q1 Loss Wider than Estimates; Iclusig Grows - Analyst Blog

ARIAD (ARIA) Q1 Loss a Penny Wider than Expected - Tale of the Tape

ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q1 2015 Results - Earnings Call Transcript

Interesting ARIA Put Options For June 26th

ARIAD Pharmaceuticals (ARIA) Q1 2015 Results - Earnings Call Webcast

Health Care Sector Update for 05/06/2015: NXTM, PGNX, ARIA

Will ARIAD's (ARIA) Iclusig Drive Sales this Earnings? - Analyst Blog

See More ARIA News...

ARIA's Top Competitors

ARIA $9.07 (2.55%)
Current stock: ARIA
GILD $111.71 (0.44%)
Current stock: GILD
CELG $116.09 (-0.09%)
Current stock: CELG
AMGN $163.59 (-0.15%)
Current stock: AMGN